Sound waves open Brain's defenses to attack deadly tumors
NCT ID NCT03551249
Summary
This study tested whether a focused ultrasound device called ExAblate could safely and temporarily open the blood-brain barrier—a natural protective layer—in patients with aggressive brain tumors (glioblastoma). The goal was to see if opening this barrier could help standard chemotherapy drugs reach the tumor area more effectively. Researchers enrolled 20 patients who were already scheduled to receive chemotherapy to evaluate the safety and feasibility of this approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
University of Maryland
Baltimore, Maryland, 21201, United States
-
University of Virginia
Charlottesville, Virginia, 22908, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States
Conditions
Explore the condition pages connected to this study.